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Purpose: to examine the effect of the adoption of endovascular aneurysm repair (EVAR) on the outcome of open repair
(OR).
Methods: between May 1998 and December 2001, EVAR (Zenith) was performed in 117 patients, and OR was performed
because of anatomic restrictions in 40 (group A), and because of young age in 11 patients (group B).
Results: EVAR patients had higher ASA classifications (p5 0.0001). EVAR was associated with a 98.3% (115 patients)
technical success rate, one conversion to OR and one fatal cardiac arrest. Thirty-day mortality was 2.6% (3 patients) in
EVAR, 15% (6 patients) in group A and none in group B. There was no difference in late survival between the three groups.
Late reinterventions, mainly endovascular, were more frequent in EVAR. At a median follow-up of 17 months one stent-
graft had migrated 5 mm distally and five stents had fractured, but without clinical consequence.
Conclusions: EVAR provides good results even with inclusion of high-risk patients. The adoption of EVAR may adversely
affect the results of OR offered to patients because of anatomic considerations. However, OR continues to be the first option
for low-risk young patients.
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Introduction
While endovascular AAA repair (EVAR) has several
advantages over open surgical repair (OR) in the
short-term,1±5 there is still concern regarding its dur-
ability. Furthermore, the adoption of EVAR may affect
the results of OR by altering the patient selection and
demographics. The aim of this study is to evaluate
current AAA management in a center applying both
open and endovascular repairs.
Methods
Patients
Between May 1998 and December 2001 168 con-
secutive patients underwent repair of non-ruptured
infrarrenal AAA at our university tertiary referral
center (Table 1). Indications for treatment were asymp-
tomatic aneurysms larger than 5 cm or symptomatic
non-ruptured AAAs. EVAR was offered as the first
option whenever adequate proximal and distal
implantation sites were present (summarized below),
with the exception of patients considered to have
a long life expectancy (410 years) based on age and
co-morbidity. One-hundred and seventeen patients
underwent EVAR (98 males/19 females, mean age
(range) 73 (68±78) years). Fifty-one patients under-
went OR, 40 (25 males/15 females, 73 (70±74) years)
because of unfavorable anatomy for EVAR (group A)
and 11 (10 males/1 female, 65 (58±66) years) because
of life expectancy (410 years) (group B).
Preoperative imaging
Preoperative evaluation included clinical examination
and contrast-enhanced spiral CT in all patients. In
addition, digital subtraction angiography (DSA) was
performed in all EVAR patients. The shortest trans-
verse diameter of the arteries was measured using
calipers against a centimeter scale on hard-copy
films by the same observer. AAA diameter was
measured at its widest portion. The aorta between
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the lowest renal artery and the beginning of the aneur-
ysm is referred to as the proximal neck in all groups.
Neck diameter was measured at the level of the
lowest renal artery. Neck angulation was measured
between the neck and aneurysm longitudinal axis.
The criteria for anatomic suitability to EVAR included
proximal neck diameter 30 mm, angulation 90
and length 12 mm. For distal implantation, at least
one common iliac artery distal diameter  20 mm was
required. Aortic anatomic characteristics are detailed
in Table 2.
Surgical procedures
EVAR was performed with Zenith stent-grafts (Cook
Europe A/S, Bjaeverskov, Denmark).6,7 One hundred
and two bifurcated, 13 aorto-uniliac and two aorto-
aortic stent-grafts were used. Sixty-five of the bifur-
cated stent-grafts were of the Zenith Tri-Fab version.8
All EVAR procedures were done in the operating
theater. A portable C-arm (Siremobil 2000, Siemens,
Erlangen, Germany) was used until October 2000.
Since then an operating room fully equipped as an
angio suite (Angiostar Plus OR, Siemens, Erlangen,
Germany) has been used. Technical success was
defined according to recommended standards.9
Open aneurysm repair was performed through a
midline or transverse transperitoneal incision with
implantation of a dacron graft (Cooley Veri-Soft;
Meadox Medicals Inc, Oakland, CA, U.S.A. and
Gelsoft, Vascutech, Glasgow, U.K.). In group A an
infrarenal aortic clamp was placed in 32 patients
(80%). In the remaining eight patients, four patients
(10%) required a suprarenal clamp and in the other
four patients the aorta was clamped between the
origin of the renal arteries. The aortic occlusion
clamp was placed below the renal arteries in all 11
patients in group B (Table 3).
Table 1. Patients' characteristics.
EVAR Open repair (OR) p
Group A Group B
Age
Median (IQR) 73 (68±78) 73 (70±74) 65 (58±66) 0.0002
Range 53±85 57±82 56±76
Sex
Male/Female 98/19 (84/16%) 25/15 (62/38%) 10/1 (91/9%) 0.0103
Symptomatic AAAs 29 (25%) 7 (18%) 1 (9%) N.S.
CAD 54 (47%) 20 (50%) 5 (45%) N.S.
CHF 17 (15%) 4 (10%) 0 (0%) N.S.
COPD 30 (26%) 11 (28%) 0 (0%) N.S.
Renal insufficiency 8 (7%) 2 (5%) 0 (0%) N.S.
Hypertension 68 (59%) 16 (40%) 6 (55%) N.S.
Diabetes 8 (7%) 5 (12%) 1 (9%) N.S.
ASA
I 0 (0%) 0 (0%) 2 (18%) 50.0001
II 9 (8%) 25 (62%) 6 (55%)
III 89 (76%) 14 (35%) 3 (27%)
IV 19 (16%) 1 (2%) 0 (0%)
Group A: anatomic restrictions for EVAR. Group B: long-life expectancy patients. CAD, Coronary artery
disease. CHF, Chronic heart failure. COPD, Chronic obstructive pulmonary disease. ASA, American
Society of Anesthesiology Classification.
Table 2. Aneurysm morphologies.
EVAR Open repair patients (OR)
Group A Group B
AAA diameter (mm) 59 (53±66) 58 (52±70) 52 (48±62)
Neck length (mm) 28 (20±35) 10 (5±15) 34 (25±40)
Neck angulation () 45 (30±60) 30 (20±60) 35 (15±82)
Neck diameter (mm) 23 (22±26) 26 (22±30) 24 (22±28)
Maximal iliac
diameter (mm)
25 (23±30) 22 (20±28) 25 (22±32)
Group A: anatomic restrictions for EVAR. Group B: long-life expec-
tancy patients. Values are expressed as the median and the IQR in
between parentheses.
Table 3. Replacement grafts in patients undergoing open repair of
their AAAs.
Group A Group B
Aorto-aortic 23 (58%) 8 (73%)
Aortobiiliac 11 (28%) 2 (18%)
Aortobifemoral 5 (12%) 1 (9%)
Aortoiliac-femoral 1 (2%) 0 (0%)
Group A: anatomic restrictions for EVAR. Group B: long-life expec-
tancy patients.
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Follow-up protocol
All patients were seen at the outpatient clinic at
1 month postoperatively and yearly thereafter. EVAR
patients, in addition, had a contrast-enhanced CT and
a plain abdominal film at the same intervals. Angio-
graphy was selectively performed whenever an inter-
vention was required. AAA diameter changes were
considered significant whenever  5 mm.9 Post-
operative complications were classifed as early (530
days) or late, and according to the recommended
standards,9 modified by adding non-ischaemic gastro-
intestinal complications.
Study design
Data from EVAR patients was collected prospectively
in a computerized database. Data from OR patients was
obtained retrospectively from clinical charts, operative
reports, death certificates and autopsy reports.
Statistical analysis
Statistical analysis was done in Statview 5.0 (SAS
Institute Inc, Cary, NC, U.S.A.). Normal distribution
was not assumed. Values are presented as medians
and interquartile range (IQR) in-between parenthesis
when not stated otherwise. Mann±Whitney U-test and
Kruskal±Wallis test were used for unpaired compari-
sons. Chi-square analysis was applied to compare
proportions. Survival analysis was performed
according to Kaplan±Meier with significance calcu-
lated with a Peto±Peto±Wilcoxon test. The follow-up
time for the cumulative survival was truncated at 44
months for the open surgery groups since this was the
longest follow-up duration of the EVAR group.
Results were considered significant when p5 0.05.
Exact p-values are presented whenever statistically
significant.
Results
Patients characteristics
There were more women in group A than the other
two groups (p 0.0103). EVAR patients had higher
American Society of Anesthesiology (ASA) scores
than group A patients (p5 0.0001) (Table 1). Proximal
aneurysm necks were significantly shorter in group A
than in the other two groups (p5 0.0001). There were
no differences in AAA size, proximal neck angulation
or comorbidity between the three groups (Table 2); nor
was there any difference between EVAR and group A
patients.
Intra-operative results
Operative time was 184 min (148±235) in EVAR,
204 min (171±258) in group A and 170 min (147±192)
in group B (pN.S.). Blood losses were significantly
lower in EVAR (0.5 l (0.3±0.9) compared to the OR
groups (2.4 (1.6±4.1) and 2.0 (1.7±2.3) litres in group
A and B, respectively) (p5 0.0001). EVAR technical
success was achieved in 115 patients (98.3%). One
patient underwent a successful immediate conversion
to OR due to incomplete deployment in a severely
angled suprarenal aorta. The other immediate failure
was a fatal cardiac arrest at the end of an otherwise
uneventful EVAR. Intra-operative adjunctive proce-
dures were required in 52 EVAR (44.4%) (Table 4), 11
group A and 2 group B patients (Table 5).
Table 4. Intraoperative adjunctive procedures in EVAR patients.
Type of procedure Number of procedures
(52 patients)
Ballon expandable stents for proximal
type I endoleak
23
Proximal extensions 6
Distal extensions 19
Stent/Stent-grafts for limb kink correction 16/6
Renal stent (fabric encroachment/
preexisting stenosis)
5 (3/2)
Proximal neck banding 2
Femoral or iliac arteries endarterectomy 2
Internal to external iliac artery transposition 1
Table 5. Intraoperative adjunctive procedures in open repair
patients.
Type of procedure Number of procedures
Group A
(11 patients)
Group B
(2 patients)
Unilateral aorto-renal bypass 2
Polar renal artery reimplantation 1
IMA reimplantation 1
Graft-femoral bypass 1 1
Femoro-femoral cross-over bypass 1
Lower limb thrombectomy 5
Suprarenal clamp  1
Y-en Roux bowel reconstruction y 1
Umbilical hernia repair 1
Group A: anatomic restrictions for EVAR. Group B: long-life expec-
tancy patients. IMA: Inferior mesenteric artery.Aortic occlusion clamp moved to suprarenal position to control
anastomotic bleeding.
y Intraoperative iatrogenic duodenal lesion in a patient submitted
2 months before to an aborted attempt of open AAA repair.
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Perioperative mortality and morbidity
Thirty-day mortality in group A (6 patients, 15%)
was higher than in group B (none) and EVAR group
(3 patients, 2.6%, p 0.0076). Early post-operative
complications were more frequent in group A than
in EVAR patients (p 0.0036) (Table 6). Incisional her-
nias requiring surgical repair developed in two OR
patients (one in each group). In EVAR patients there
were three late vascular occlusive complications
caused by stent-graft limb failure.
Reinterventions
Early reinterventions were necessary in seven (6.0%)
(Table 7) and late reinterventions in eight (6.8%) EVAR
patients. Four patients (3.4%) were readmitted one
year after EVAR for embolization of a type II endoleak.
In one, the procedure was repeated 10 months later
due to recurrence. Kissing stents were used in kinked
stent-graft limbs of two patients at 1.5 and 2 months
post stent-graft implantation. In one of these patients a
thrombectomy was also performed. A stent-graft was
placed at 8 months to correct an impending separation
of the contralateral stent-graft limb. A femoro-femoral
cross-over graft was placed 3 months postoperatively
in a patient with a stent-graft limb occlusion. One
renal artery was stented 2 months postoperatively
due to partial coverage of its ostium by the stent-
graft fabric. In another patient renal artery stenting
was done bilaterally at 14 months due to the progres-
sion of ostial stenosis. No late conversions to open
repair were performed. Early reinterventions were
necessary in five OR group A patients (12.5%) and in
none of the group B (Table 8). Late reinterventions in
OR patients consisted of two surgical repairs of inci-
sional hernias at 12 and 20 months postoperatively
(one patient of each group). The number of early rein-
terventions was not different between EVAR and OR
group A (pN.S.). Late reinterventions, though pre-
dominantly endovascular, were more frequent in the
EVAR group.
Mid-term results
Median follow-up was 21 (12±28), 26 (9±34) and 43
(28±46) months for EVAR, group A and B patients,
respectively. There were no late deaths in OR group
B. Two EVAR and one OR group A patients died
in-hospital during the second postoperative month
following complicated perioperative courses. The
cause of death was an irreversible lung edema in a
Table 6. Early post-operative complications.
EVAR
(19 patients)
Open repair patients (OR)
Group A
(16 patients)
Group B
(2 patients)
Systemic/remote
Cardiac 4 1
CNS 1
Pulmonary 7
Renal 3 5 2
GI 1 4 1
Coagulation 3
Local/vascular
Anast hemorrhage 2 1
Vascular occlusive 3 1
Colon ischemia 1
Fascial disruption
Wound infection 3 1 1
Group A: anatomic restrictions for EVAR. Group B: long-life expec-
tancy patients. CNS: Central Nervous System. GI: Gastrointestinal.
Table 7. Reinterventions in patients undergoing EVAR (15
patients, 12.8%).
Type of procedure Early
(7 patients)
Late
(8 patients)
Collateral perfusion embolization 5
Renal stent 3
Stent/stent-graft 3/0 4/1
Thrombectomy 2 1
Femoro-femoral cross-over bypass 1
Common femoral to profunda bypass 1
Exploratory laparotomy 1
Bowel ressection due to incarcerated
hernia
1
Conversion to open repair 1
Table 8. Reinterventions in patients undergoing OR (7 patients,
13.7%).
Type of procedure Group A Group B
Early
(5 patients)
Late
(1 patient)
Early
(0 patients)
Late
(1 patient)
Exploratory
laparotomy
3
Cholecystectomy
due to acalculous
cholecystitis
2
Ileocecal ressection 1
Jejunostomy 1
Gastrostomy 1
Femoro-popliteal
bypass
1
Fasciotomy 1
Tracheostomy 2
Skin transplantation 1
Incional hernia
repair
1 1
Group A: anatomic restrictions for EVAR. Group B: long-life
expectancy patients.
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patient with severe congestive cardiomyopathy and
coronary artery disease in one EVAR patient and sep-
sis and multiorgan failure in the other two. One OR
group A patient and 11 EVAR patients died during the
remaining follow-up period. In all cases the cause of
death was verified to be non-AAA related (cardiac,
pulmonary, renal and malignancy). No difference was
found in reintervention-free and assisted survival
between OR group A and EVAR patients (Figs 1 and 2).
Reintervention-free and assisted survival at 44 months
were, respectively, 70 and 82% for EVAR patients, 71
and 78% for OR group A patients and 91 and 100% for
OR group B.
EVAR imaging follow-up
Ninety-one patients underwent imaging follow-up for
more than 3 months (median 17 months (6±30)). In
21 (23.1%) patients the AAA diameter remained
unchanged while in the remaining 70 (76.9%) it
decreased. No AAAs increased in size. Type II endo-
leaks occurred in 15 patients (16.5%), four of them
having AAAs that did not decrease in size
(p5 0.0001). No stent-graft related endoleak was
noted. In one patient the stent-graft migrated 5 mm
distally at 18 months, however the aneurysm sac con-
tinues to be well excluded. In five patients with the
bimodular costume-made Zenith stent-graft version a
fracture was identified in the stent immediately above
the flow divider. This was first seen at 6 months
(one patient), 1 year (one patient) and 3 years (three
patients) post-operatively. In all cases the aneurysms
continued to be excluded and therefore no reinterven-
tions were considered necessary. No other stent
fractures were identified.
Discussion
EVAR has repeatedly been shown to cause less intrao-
perative blood loss, shorter ICU and hospital stay, less
cardiac and pulmonary morbidity1±5,10 than OR. This
has justified the widespeard acceptance of EVAR in
high-risk patients.11±14 However, the durability of
EVAR has been questioned, namely because of mate-
rial fatigue, migration and endoleaks.2,15±17 An
attempt has been made to address these problems
through further technical developments. A continu-
ous reappraisal of the EVAR results is, therefore,
imperative. In addition, there is limited knowledge
on how EVAR influences the results of OR, since
patient demographics might have been altered.
The excellent results in our `` low-risk'' patients
(group B) supports the notion that OR should be the
first treatment option for this sub-group. EVAR pro-
vided good results even with the inclusion of patients
at high risk for open surgery (ASA IV). The clear
difference on thirty-day mortality between EVAR
and group A patients may be the result of several
factors other than the minimal invasiveness nature of
EVAR.18 For example, a higher proportion of ORs
are for juxtarenal AAAs while, at the same time, the
Fig. 1. Kaplan±Meier for reintervention-free survival.
Fig. 2. Kaplan±Meier curves for assisted survival.
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volume of OR is reduced.19±21 The greater number
of women undergoing open surgery may be another
factor.21±23 In spite of the fact that EVAR patients were
sicker (higher ASA classifications), they appear to
tolerate their procedure better than group A patients
in terms of early complications and reinterventions.
With further developments of stent-graft, the numbers
of OR may continue to fall, so exacerbating the afore-
mentioned trends.24±26 Our relative good results of
EVAR may reflect the fact that this study was
preceded by five years of EVAR experience, thus
avoiding the learning curve.27±29 Improved techniques
and use of third generation stent-graft with a strong
proximal suprarenal fixation and columnar support
may also have contributed to these results.30±34
However, our observation of fractured stents raises
serious concern about the durability of this
technique.2,15
In conclusion, EVAR provides good results even
with the inclusion of high-risk patients. The wide
application of EVAR appears to affect the results of
OR, since this tends to be performed in older patients
with severe comorbidity and challenging anatomy. OR
continues to be the standard of care for young low-risk
patients.
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